NFKB1 and neoplasm: In addition, histone-independent actions of HDACi, in particular the hyperacetylation of tumor suppressor p53, chaperone HSP90, and NF-κB subunit p65/RelA, may contribute to their effects on drug-resistant tumor cells and reflect the broad impact of HDAC/i on cancer in general [48].